NEW GLOBAL FRONTIERS IN REGULATION: THE AGE OF NANOTECHNOLOGY, Graeme Hodge, Diana Bowman, Karinne Ludlow, eds., Elgar, 2007
23 Pages Posted: 24 Nov 2008
In this Chapter, we set out the pivotal questions relating to the United States approach to nanotechnology and other emerging technologies. We note how the experiences of biotechnology regulation are likely to continue to inform United States approaches. After setting out these principles, we discuss three regulatory experiences and approaches that we believe do and will inform United States regulatory policy going forward. We examine the Coordinated Framework for the regulation of biotechnology and, in so doing, look at the actions of three separate agencies: (1) EPA; (2) FDA; and (3) NIOSH. We conclude with a high-level discussion of the various issues that remain unresolved in the United States approach.
Keywords: nanotechnology, regulation, technology, biotechnology, EPA, FDA, NIOSH, risk
Suggested Citation: Suggested Citation
Marchant, Gary E. and Sylvester, Douglas J. and Abbott, Kenneth W., Nanotechnology Regulation: The United States Approach. NEW GLOBAL FRONTIERS IN REGULATION: THE AGE OF NANOTECHNOLOGY, Graeme Hodge, Diana Bowman, Karinne Ludlow, eds., Elgar, 2007. Available at SSRN: https://ssrn.com/abstract=1305256